Project Grant R50CA288381
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $575K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Arizona, USA
Similar Awards
- The National Cancer Institute (NCI) awarded a $361,695 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of Oklahoma Health Sciences Center (OUHSC) for the period of September 1, 2025 to August 31, 2029. The grant aims to: 1) Leverage novel mHealth applications to boost enrollment in NCI-sponsored clinical trials, 2) Promote representative clinical trial enrollment from the local catchment area population, 3) Expand Veteran access to NCI trials, and 4)...
- The University of Colorado Cancer Center (UCCC) has been awarded a $547,080 Project Grant from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) to advance cancer screening and prevention trials. The grant aims to increase patient accrual and diversity in clinical trials, with a focus on expanding the number of National Clinical Trials Network (NCTN) trials and launching a new cancer prevention and survivorship modality team within the UCCC's Cancer Clinic Trials Office....
- This federal Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), supports efforts by a Columbia University researcher to develop and implement NCI-sponsored cancer clinical trials at the NCI-designated Herbert Irving Comprehensive Cancer Center (HICCC). The $193,926 award, with a project period from September 1, 2025 to August 31, 2030, will enable the researcher to: (1) develop novel HICCC investigator-led trials for...
- This $930,500 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports innovative research by the University of Arizona to understand the fundamental biological mechanisms of cancer development, progression, and potential therapeutic interventions. The research focuses on investigating the role of loss of chromosome Y (LOY) in bladder cancer, examining how LOY in both tumor cells and immune cells can promote cancer growth and induce tumor...
- The National Cancer Institute (NCI) awarded a Project Grant of $375,025 to the University of Maryland, Baltimore under the Cancer Treatment Research federal grant program (CFDA 93.395). The grant supports Dr. Mark Mishra, who plays a critical role in the University of Maryland Greenebaum Comprehensive Cancer Center's clinical trials program and NCI-funded research. The key goals of the award are to: 1) Expand access to NCI-sponsored clinical trials at new network sites; 2) Foster partnerships to...
- The University of Kansas Medical Center Research Institute, Inc. was awarded a $135,949 Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) to address barriers to enrolling patients in precision medicine clinical trials for acute myeloid leukemia (AML). The key objectives are to: 1) develop rapid in-house molecular testing capabilities to enable broader patient access to precision medicine trials, and 2) conduct community and patient...
- The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) has been awarded a $135,951 Project Grant from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to enhance access to breast cancer prevention clinical trials. The project aims to modernize engagement and delivery of cancer prevention research, with a focus on improving recruitment and representation of all populations in breast cancer prevention trials. The award supports research initiatives to...
- This $5,041,790 cooperative agreement award from the National Cancer Institute (NCI), under the Cancer Centers Support Grants program (CFDA 93.397), will fund research projects at the University of California, San Francisco (UCSF) to improve cancer health disparities. The key products and services to be delivered include: Three translational cancer health disparities research projects focused on meningioma, prostate cancer, and breast cancer. The projects aim to evaluate the interplay of...
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $833,467 to the Dana-Farber Cancer Institute, Inc. (DFCI) to develop and deploy open-source AI tools to improve cancer clinical trial feasibility and recruitment. The key products and services to be delivered include: Extending DFCI's existing MatchMiner tool to match patients to clinical trials based on additional clinical variables beyond molecular criteria, such as...
- This federal Project Grant award of $988,224.00 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports the University of California, San Diego's research program focused on advancing treatment for head and neck cancer patients with competing health risks through multi-center randomized trials. The principal investigator has extensive experience leading national clinical trials through the NRG Oncology cooperative group and serving as co-chair of the NCI Head and...